A prospective observational cohort study on IL-18 in cardiac surgery patients did not confirm the biomarker’s effectiveness as a predictor of AKI but instead linked changes in its concentration to the inflammatory process caused by the use of cardiopulmonary bypass (CBP) [30,31]. Here, IL18 is linked to acute kidney injury.